Inflammation and cardiovascular disease: From mechanisms to therapeutics

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536

Untitled work

(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501

Inflammation in Atherosclerosis

Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,796

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317

Efficacy and safety of low-dose colchicine after myocardial infarction

Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1912388 · Cited by 3,159 · cited 1×

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429

Colchicine in Patients with Chronic Coronary Disease

Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299

C-Reactive Protein Levels and Outcomes after Statin Therapy

Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250

Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome: A Randomized Trial

Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968

Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid

Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,756

Effect of Statin Therapy on C-Reactive Protein Levels

Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,644

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557

Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women: A Randomized Trial

Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511

Symptomatic atherosclerosis is associated with an altered gut metagenome

Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371 · cited 1×

HIV Infection and the Risk of Acute Myocardial Infarction

Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., Butt, A. A., Goetz, M. B., Leaf, D. A., Oursler, K. A., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3728 · Cited by 1,340

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325

An overview of microRNAs

Hammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,324

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317

Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.

Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O’Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315

Oxidative Stress in Atherosclerosis

Kattoor, A. J., Pothineni, N. V. K., Palagiri, D. R., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,309

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data

Oikonomou, E. K., Marwan, M., Desai, M. Y., Mâncio, J., Alashi, A., Hutt, E., Thomas, S., Herdman, L., Kotanidis, C. P., Thomas, K. E. H., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31114-0 · Cited by 1,210

Utilization of Nutrients by Isolated Epithelial Cells of the Rat Colon

Roediger, W. E. W. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80339-9 · Cited by 1,187

C-reactive protein, fibrinogen, and cardiovascular disease prediction

The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150

Detecting human coronary inflammation by imaging perivascular fat

Antonopoulos, A. S., Sanna, F., Sabharwal, N. K., Thomas, S., Oikonomou, E. K., Herdman, L., Margaritis, M., Shirodaria, C. C., Kampoli, A., Akoumianakis, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2658 · Cited by 1,129

Inflammation and cardiovascular disease mechanisms

Libby, P. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.456s · Cited by 1,114

Myocardial infarction accelerates atherosclerosis

Dutta, P., Courties, G., Wei, Y., Leuschner, F., Gorbatov, R., Robbins, C. S., Iwamoto, Y., Thompson, B. D., Carlson, A. L., Heidt, T., et al. (2012) · Nature · doi:10.1038/nature11260 · Cited by 1,109

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6

Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095

Bone Formation and Inflammation in Cardiac Valves

Mohler, E. R., Gannon, F. H., Reynolds, C. A., Zimmerman, R. A., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,067

Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease

Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,059

Transcriptional control of the inflammatory response

Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035

Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase

Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035

Pro‐ and anti‐inflammatory cytokine balance in strenuous exercise in humans

Ostrowski, K., Rohde, T., Asp, S., Schjerling, P., & Pedersen, B. K. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.287ad.x · Cited by 1,014

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010

From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection

Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial

O’Donoghue, M. L., Fazio, S., Giugliano, R. P., Stroes, E. S. G., Kanevsky, E., Gouni-Berthold, I., Im, K., Lira Pineda, A., Wasserman, S. M., Češka, R., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037184 · Cited by 984 · cited 1×

Effects of tobacco smoke on immunity, inflammation and autoimmunity

Arnson, Y., Shoenfeld, Y., & Amital, H. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.003 · Cited by 966

Low-grade inflammation, diet composition and health: current research evidence and its translation

Minihane, A. M., Vinoy, S., Russell, W. R., Baka, A., Roche, H. M., Tuohy, K. M., Teeling, J. L., Blaak, E. E., Fenech, M. F., Vauzour, D., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002093 · Cited by 962

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

Joshi, N. V., Vesey, A. T., Williams, M. C., Shah, A. S. V., Calvert, P. A., Craighead, F., Yeoh, S. E., Wallace, W. A., Salter, D. M., Fletcher, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61754-7 · Cited by 953

Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB

Seldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911

Mast Cell: A Multi-Functional Master Cell

Krystel‐Whittemore, M., Dileepan, K. N., & Wood, J. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00620 · Cited by 892

Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles

FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875

microRNA Regulation of Inflammatory Responses

O'Connell, R. M., Rao, D. S., & Baltimore, D. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075013 · Cited by 843

Vascular Adhesion Molecules in Atherosclerosis

Galkina, E., & Ley, K. F. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149179 · Cited by 831

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823

Inflammation and plaque vulnerability

Hansson, G. K., Libby, P., & Tabas, I. A. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 809

Myeloperoxidase and Cardiovascular Disease

Nicholls, S. J., & Hazen, S. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163262.83456.6d · Cited by 805

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799

Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans

Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M., & Pedersen, B. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-0670fje · Cited by 790

Apoptosis Regulates Human Vascular Calcification In Vitro: Evidence for Initiation of Vascular Calcification by Apoptotic Bodies

Proudfoot, D., Skepper, J. N., Hegyi, L., Bennett, M. R., Shanahan, C. M., & Weissberg, P. L. (2000) · Circulation Research · doi:10.1161/01.res.87.11.1055 · Cited by 719

Monocyte-macrophages and T cells in atherosclerosis

Tabas, I., & Lichtman, A. H. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.008 · Cited by 646

Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure

Gielen, S., Adams, V., Möbius-Winkler, S., Linke, A., Erbs, S., Yu, J., Kempf, W., Schubert, A., Schuler, G., & Hambrecht, R. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00848-9 · Cited by 613

Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials

Schwingshackl, L., & HOFFMANN, G. E. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.03.003 · Cited by 612

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

The STABILITY Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315878 · Cited by 579

Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression

Puri, R., Nicholls, S. J., Shao, M., Kataoka, Y., Uno, K., Kapadia, S. R., Tuzcu, E. M., & Nissen, S. E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.036 · Cited by 571

Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease

Lindmark, E., Diderholm, E., Wallentin, L. C., & Siegbahn, A. (2001) · JAMA · doi:10.1001/jama.286.17.2107 · Cited by 563

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies

Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544 · cited 1×

Dietary α-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women

Zhao, G., Etherton, T. D., Martin, K. R., West, S. G., Gillies, P. J., & Kris‐Etherton, P. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.11.2991 · Cited by 532

Tumor Necrosis Factor-α Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway

Tintut, Y., Patel, J., Parhami, F., & Demer, L. L. (2000) · Circulation · doi:10.1161/01.cir.102.21.2636 · Cited by 528

Leptin resistance

Martin, S. S., Qasim, A., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.060 · Cited by 516

Genetics of Human Cardiovascular Disease

Kathiresan, S., & Srivastava, D. (2012) · Cell · doi:10.1016/j.cell.2012.03.001 · Cited by 513

Trimethylamine N-oxide: the good, the bad and the unknown.

Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504

Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

Serruys, P. W. J. C., García‐García, H. M., Buszman, P. E., Erné, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, Ø., Dudek, D., Bøtker, H. E., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.771899 · Cited by 498

Role of Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis

Zalewski, A. A., & Macphee, C. H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 476

Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study

Baer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476

Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women

Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., & Ridker, P. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000029781.31325.66 · Cited by 470

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

Naranjo, A., Sokka, T., Descalzo, M. Á., Alén, J. C., Hørslev‐Petersen, K., Luukkainen, R., Combe, B. G., Burmester, G. R., Devlin, J., Ferraccioli, G., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2383 · Cited by 464

Estrogen alters thresholds for B cell apoptosis and activation

Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D., & Diamond, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14873 · Cited by 461

Dietary pattern, inflammation, and incidence of type 2 diabetes in women

Schulze, M. B., Hoffmann, K., Manson, J. E., Willett, W. C., Meigs, J. B., Weikert, C., Heidemann, C., Colditz, G. A., & Hu, F. B. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.675 · Cited by 457

Myeloperoxidase – A bridge linking inflammation and oxidative stress with cardiovascular disease

Ndrepepa, G. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.022 · Cited by 452

Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals

Meuwese, M. C., Stroes, E. S. G., Hazen, S. L., van Miert, J. N. I., Kuivenhoven, J. A., Schaub, R. G., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.033 · Cited by 444

Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials

Antonopoulos, A. S., Margaritis, M., Lee, R., Channon, K. M., & Antoniades, C. A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504803 · Cited by 440

Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

Sampson, U. K., Fazio, S., & Linton, M. F. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0219-7 · Cited by 439 · cited 1×

Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease

Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., LENNON, L. T., & Whincup, P. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi183 · Cited by 430

Physical activity and modulation of systemic low-level inflammation

Bruunsgaard, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505247 · Cited by 429

Estrogen alters thresholds for B cell apoptosis and activation

Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D., & Diamond, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214873 · Cited by 427

Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke

Oei, H.-H. S., van der Meer, I. M., Albert Hofman, D., Koudstaal, P. J., Stijnen, T., Breteler, M. M. B., & Witteman, J. C. M. (2005) · Circulation · doi:10.1161/01.cir.0000154553.12214.cd · Cited by 423

Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques

Hutcheson, J. D., Goettsch, C., Bertazzo, S., Maldonado, N., Ruiz, J. L., Goh, W., Yabusaki, K., Faits, T., Bouten, C., Franck, G., et al. (2016) · Nature Materials · doi:10.1038/nmat4519 · Cited by 419

The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions

Trøseid, M., Andersen, G. Ø., Broch, K., & Hov, J. R. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102649 · Cited by 416

GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation

Otvos, J. D., SHALAUROVA, I. Y., Wolak, J. E., Connelly, M. A., Mackey, R. H., Stein, J. H., & Tracy, R. P. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.232918 · Cited by 408

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid

Mason, R. P., Libby, P., & Bhatt, D. L. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313286 · Cited by 407

Physical training reduces peripheral markers of inflammation in patients with chronic heart failure

Adamopoulos, S. N. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2285 · Cited by 373

The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review

Schoenfeld, S. R., Kasturi, S., & Costenbader, K. H. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.12.002 · Cited by 370

Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment

Tahamtan, A., Teymoori‐Rad, M., Nakstad, B., & Salimi, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01377 · Cited by 368

Exercise training modulates cytokines activity in coronary heart disease patients

Goldhammer, E., Tanchilevitch, A., Maor, I., Beniamini, Y., Rosenschein, U., & Sagiv, M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.073 · Cited by 363

Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries

Kelly-Arnold, A., Maldonado, N., Laudier, D. M., Aikawa, E. R., Cardoso, L., & Weinbaum, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308814110 · Cited by 356

The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation

Martínez, G. J., Celermajer, D. S., & Patel, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.027 · Cited by 356

Exercise, inflammation and aging.

(2012) · Europe PMC (PubMed Central) · Cited by 345

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT

Bohula, E. A., Giugliano, R. P., Cannon, C. P., Zhou, J., Murphy, S. A., White, J. A., Tershakovec, A. M., Blazing, M. A., & Braunwald, E. (2015) · Circulation · doi:10.1161/circulationaha.115.018381 · Cited by 340

Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

Ortego, M., Bustos, C., Hernández-Presa, M. Á., Tuñón, J., Díaz, C., Hernández, G., & Egido, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00193-8 · Cited by 339

Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study

Kaplan, H., Thompson, R. C., Trumble, B. C., Wann, L. S., Allam, A. H., Beheim, B., Frohlich, B., Sutherland, M. L., Sutherland, J. D., Stieglitz, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30752-3 · Cited by 338

Hypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages

Folco, E. J. E., Sheikine, Y., Rocha, V. Z., Christen, T., Shvartz, E., Sukhova, G. K., Carli, M. F. D., & Libby, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.044 · Cited by 332

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Bouabdallaoui, N., Tardif, J., Waters, D. D., Pinto, F. J., Maggioni, A. P., Díaz, R., Berry, C., Köenig, W., López-Sendón, J., Gamra, H., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa659 · Cited by 325

Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses

Nizri, E., Irony-Tur-Sinai, M., Lory, O., Orr‐Urtreger, A., Lavi, E., & Brenner, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902212 · Cited by 315

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism

Altomonte, J., Lin, C., Harbaran, S., Richter, A. M., Xu, J., Meseck, M. L., & Dong, H. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19992 · Cited by 312

Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials

Fedewa, M. V., Hathaway, E. D., & Ward-Ritacco, C. L. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-095999 · Cited by 309

Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise

Sanford, J. A., Nogiec, C. D., Lindholm, M. E., Adkins, J., Amar, D., Dasari, S., Drugan, J. K., Fernández, F. M., Radom‐Aizik, S., Schenk, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.004 · Cited by 309

Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A. M., Rifai, N., Califf, R. M., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.106.628909 · Cited by 305

Fractionation of Aqueous Cigarette Tar Extracts: Fractions That Contain the Tar Radical Cause DNA Damage

Pryor, W. A., Stone, K., Zang, L., & Bermúdez, E. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970159y · Cited by 302

Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway

Geng, J., Yang, C., Wang, B., Zhang, X., Hu, T., Gu, Y., & Li, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.016 · Cited by 297

The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases

Casas, R. M., Sacanella, E., & Estruch, R. (2014) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530314666140922153350 · Cited by 294

Adiponectin - Its Role in Metabolism and Beyond

Stefan, N., & Stümvoll, M. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-34785 · Cited by 293

The role of efferocytosis in atherosclerosis

Kojima, Y., Weissman, I. L., & Leeper, N. J. (2017) · Circulation · doi:10.1161/circulationaha.116.025684 · Cited by 289

Targeting inflammation in metabolic syndrome

Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287

Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

Grünfeld, C., Kotler, D. P., Shigenaga, J. K., Doerrler, W. T., Tierney, A. R., Wang, J., Pierson, R. N., & Feingold, K. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80154-e · Cited by 286

Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Grunfeld, C., Kotler, D. P., Shigenaga, J. K., Doerrler, W., Tierney, A., Wang, J., Pierson, R. N., & Feingold, K. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90536-7 · Cited by 286

Inflammatory and Cholesterol Risk in the FOURIER Trial

Bohula, E. A., Giugliano, R. P., Leiter, L. A., Verma, S., Park, J.-G., Sever, P. S., Lira Pineda, A., Honarpour, N., Wang, H., Murphy, S. A., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034032 · Cited by 280

Intestinal Microbiota‐Generated Metabolite Trimethylamine‐ N‐ Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort

Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67478 · Cited by 269 · cited 8×

Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit

Brites, F. D., Martín, M., Guillas, I., & Kontush, A. (2017) · BBA Clinical · doi:10.1016/j.bbacli.2017.07.002 · Cited by 265

Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events

Emami, H., Singh, P., MacNabb, M. H., Vucic, E., Lavender, Z. R., Rudd, J. H. F., Fayad, Z. A., Lehrer‐Graiwer, J., Korsgren, M., Figueroa, A. L., et al. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.10.009 · Cited by 263

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism

Altomonte, J., Lin, C., Harbaran, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419992 · Cited by 260

Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy

Pradhan, A. D., Aday, A. W., Rose, L. M., & Ridker, P. M. (2018) · Circulation · doi:10.1161/circulationaha.118.034645 · Cited by 258

Effects of Physical Activity on Cardiovascular Disease

Ahmed, H. M., Blaha, M. J., Nasir, K., Rivera, J. J., & Blumenthal, R. S. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.042 · Cited by 253

The Chemical Components of Tobacco and Tobacco Smoke

Cooke, M. (2010) · Chromatographia · doi:10.1365/s10337-010-1556-3 · Cited by 250

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima‐Media Thickness in HIV‐Infected Patients Receiving Antiretroviral Therapy

Ross, A. C., Rizk, N., O’Riordan, M. A., Dogra, V. S., El‐Bejjani, D., Storer, N. J., Harrill, D., Tungsiripat, M., Adell, J., & McComsey, G. A. (2009) · Clinical Infectious Diseases · doi:10.1086/605578 · Cited by 248

Relationship of Cigarette Smoking With Inflammation and Subclinical Vascular Disease

McEvoy, J. W., Nasir, K., DeFilippis, A. P., Lima, J. A. C., Bluemke, D. A., Hundley, W. G., Barr, R. G., Budoff, M. J., Szklo, M., Navas‐Acién, A., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304960 · Cited by 246

Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden

Senthong, V., Li, X. S., Hudec, T., Coughlin, J., Wu, Y., Levison, B., Wang, Z., Hazen, S. L., & Tang, W. H. W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.546 · Cited by 242

The Relationship between Lung Inflammation and Cardiovascular Disease

van Eeden, S. F., Leipsic, J. A., Man, S. F. P., & Sin, D. D. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0455pp · Cited by 241

Infections, atherosclerosis, and coronary heart disease

Pothineni, N. V. K., Subramany, S., Kuriakose, K., Shirazi, L. F., Romeo, F., Shah, P. K., & Mehta, J. L. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx362 · Cited by 241

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

Ridker, P. M., MacFadyen, J. G., Thuren, T. Y., & Libby, P. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz542 · Cited by 241

PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1

Ding, Z., Pothineni, N. V. K., Goel, A., Lüscher, T. F., & Mehta, J. L. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz313 · Cited by 240

Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l

Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P., & Braunwald, E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.080 · Cited by 236

High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway

Xia, P., Vadas, M. A., Rye, K., Barter, P. J., & Gamble, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33143 · Cited by 235

Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey

Bakhru, A., & Erlinger, T. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020160 · Cited by 229

Sedentary Time and Markers of Chronic Low-Grade Inflammation in a High Risk Population

Henson, J. J., Yates, T. E., Edwardson, C. L., Khunti, K. K., Talbot, D. C. S., Gray, L. J., Leigh, T. M., Carter, P., & Davies, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078350 · Cited by 219

Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling

Antoniades, C., Bakogiannis, C., Leeson, P., Guzik, T. J., Zhang, M.-H., Tousoulis, D., Antonopoulos, A. S., Demosthenous, M., Marinou, K., Hale, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.985150 · Cited by 219

Colchicine in Patients with Chronic Coronary Disease

Lucijanić, M., Javor, E., & Skelin, M. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2034992 · Cited by 219

Nicotine Strongly Activates Dendritic Cell–Mediated Adaptive Immunity

Aicher, A., Heeschen, C., Mohaupt, M., Cooke, J. P., Zeiher, A. M., & Dimmeler, S. (2003) · Circulation · doi:10.1161/01.cir.0000047279.42427.6d · Cited by 213

Trans fatty acids – Effects on systemic inflammation and endothelial function

Mozaffarian, D. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.04.007 · Cited by 212

Inflammation and Atherothrombosis

Libby, P., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.011 · Cited by 204

Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Reactive Protein Independent of Aspirin and Atorvastatin in Patients With Stable Coronary Artery Disease

Nidorf, M., & Thompson, P. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.039 · Cited by 202

HDL-mediated mechanisms of protection in cardiovascular disease

Kontush, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu147 · Cited by 198

Upregulation of CD40 and CD40 Ligand (CD154) in Patients With Moderate Hypercholesterolemia

Garlichs, C. D., John, S., Schmeißer, A., Eskafi, S., Stumpf, C., Karl, M., Goppelt‐Struebe, M., Schmieder, R. E., & Daniel, W. G. (2001) · Circulation · doi:10.1161/hc4501.099312 · Cited by 194

Anti‐Inflammatory Effects of a Vegan Diet Versus the American Heart Association–Recommended Diet in Coronary Artery Disease Trial

Shah, B., Newman, J. D., Woolf, K., Ganguzza, L., Guo, Y., Allen, N., Zhong, J., Fisher, E. A. A., & Slater, J. N. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011367 · Cited by 194

Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation

Gonçalves, I., Edsfeldt, A., Ko, N. Y., Grufman, H., Berg, K., Björkbacka, H., Nitulescu, M., Persson, A. F., Nilsson, M., Prehn, C. P., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249854 · Cited by 188

High–glycemic index carbohydrate increases nuclear factor-κB activation in mononuclear cells of young, lean healthy subjects

Dickinson, S., Hancock, D. P., Petocz, P., Ceriello, A., & Brand-Miller, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1188 · Cited by 184

High dose and long-term statin therapy accelerate coronary artery calcification

Henein, M., Granåsen, G., Wiklund, U., Schmermund, A., Guerci, A., Erbel, R., & Raggi, P. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.072 · Cited by 181

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study

Ahlehoff, O., Skov, L., Gislason, G., Lindhardsen, J., Kristensen, S. L., Iversen, L., Lasthein, S., Gniadecki, R., Dam, T. N., Torp-Pedersen, C. T., et al. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02593.x · Cited by 179

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

Mackness, B., Hine, D. G., Liu, Y., Mastorikou, M., & Mackness, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.056 · Cited by 178

The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study

Panagiotakos, D. B., Pitsavos, C. S., Chrysohoou, C. A., Kavouras, S. A., & Stefanadis, C. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.07.010 · Cited by 176

Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease

Sun, Q., Ma, J., Campos, H., & Hu, F. B. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.929 · Cited by 171

Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions

Shao, B., Pennathur, S., & Heinecke, J. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337345 · Cited by 170

Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI

Fernández‐Friera, L., Fuster, V., López‐Melgar, B., Oliva, B., Sánchez‐Gonzalez, J., Macías, A., Pérez-Asenjo, B., Zamudio, D., Farto, J. C. A., España, S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.075 · Cited by 168

The Western lifestyle has lasting effects on metaflammation

Christ, A., & Latz, E. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0156-1 · Cited by 158

Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies

Andreotti, F., Porto, I., Crea, F., & Maseri, A. (2002) · Heart · doi:10.1136/heart.87.2.107 · Cited by 156

Dietary fiber, inflammation, and cardiovascular disease

King, D. E. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400112 · Cited by 155

Relations of glycemic index and glycemic load with plasma oxidative stress markers

Hu, Y., Block, G., Norkus, E. P., Morrow, J. D., Dietrich, M., & Hudes, M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.70 · Cited by 154

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis

Jin, Y. H., & Fu, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012219 · Cited by 153

Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis

Dweck, M. R., Aïkawa, E., Newby, D. E., Tarkin, J. M., Rudd, J. H. F., Narula, J., & Fayad, Z. A. (2016) · Circulation Research · doi:10.1161/circresaha.116.307971 · Cited by 148

Chemokines are elevated in plasma after strenuous exercise in humans

Ostrowski, K., Rohde, T., Asp, S., Schjerling, P., & Pedersen, B. K. (2001) · European Journal of Applied Physiology · doi:10.1007/s004210170012 · Cited by 146

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

Mackness, B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(04)00780-6 · Cited by 145

Smoking status and differential white cell count in men and women in the EPIC-Norfolk population

Smith, M. R., Kinmonth, A., Luben, R., Bingham, S. A., Day, N., Wareham, N. J., Welch, A. A., & Khaw, K. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00200-4 · Cited by 144

Simvastatin inhibits MMP‐9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP‐9 mRNA levels

Turner, N. A., O'Regan, D. J., Ball, S. G., & Porter, K. E. (2005) · The FASEB Journal · doi:10.1096/fj.04-2852fje · Cited by 143

Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events

Duprez, D. A., Otvos, J. D., Sanchez, O. A., Mackey, R. H., Tracy, R. P., & Jacobs, D. R. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255828 · Cited by 142

Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

Kim, S., Kang, H., Jhon, M., Kim, J., Lee, J., Walker, A. J., Agustini, B., Kim, J., & Berk, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00103 · Cited by 142

The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis

Skagen, K., Trøseid, M., Ueland, T., Holm, S., Abbas, A., Gregersen, I., Kummen, M., Bjerkeli, V., Reier-Nilsen, F., Russell, D., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.033 · Cited by 139

Effect of Dietary Sugar Intake on Biomarkers of Subclinical Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies

Corte, K. W. D., Perrar, I., Penczynski, K. J., Schwingshackl, L., Herder, C., & Buyken, A. E. (2018) · Nutrients · doi:10.3390/nu10050606 · Cited by 138

Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention

Guedeney, P., Claessen, B. E. P. M., Kalkman, D. N., Aquino, M. B., Sorrentino, S., Giustino, G., Farhan, S., Vogel, B., Sartori, S., Montalescot, G., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.077 · Cited by 134

PCSK9 inhibition and inflammation: A narrative review

Ruscica, M., Tokgözoğlu, L. S., Corsini, A., & Sirtori, C. R. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.015 · Cited by 133

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis

† (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00034-0 · Cited by 132

Tsimané: Das gesündeste Volk der Welt

(2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-106661 · Cited by 127

Effect of bariatric surgery on serum inflammatory factors of obese patients: a systematic review and meta-analysis

Askarpour, M., Khani, D., Sheikhi, A., Ghaedi, E., & Alizadeh, S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03926-0 · Cited by 120

The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study

Pitsavos, C., Panagiotakos, D. B., Chrysohoou, C. A., Kavouras, S. A., & Stefanadis, C. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000164690.50200.43 · Cited by 117

Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect

Raggi, P., Gadiyaram, V., Zhang, C., Chen, Z., Lopaschuk, G., & Stillman, A. E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013104 · Cited by 113

Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study

Glynn, R. J., MacFadyen, J. G., & Ridker, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.120642 · Cited by 107

Cigarette Smoking and Cardiovascular Events

McEvoy, J. W., Blaha, M. J., DeFilippis, A. P., Lima, J. A. C., Bluemke, D. A., Hundley, W. G., Min, J. K., Shaw, L. J., Lloyd‐Jones, D. M., Barr, R. G., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304562 · Cited by 104

The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA)

Rifai, M. A., DeFilippis, A. P., McEvoy, J. W., Hall, M. E., Acien, A. N., Jones, M. R., Keith, R. J., Magid, H. S. A., Rodríguez, C. J., Barr, R. G., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.021 · Cited by 104

Associations of Cigarette Smoking With Subclinical Inflammation and Atherosclerosis: ELSA‐Brasil (The Brazilian Longitudinal Study of Adult Health)

Kianoush, S., Yakoob, M. Y., Al‐Rifai, M., DeFilippis, A. P., Bittencourt, M. S., Duncan, B. B., Benseñor, I. M., Bhatnagar, A., Lotufo, P. A., & Blaha, M. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005088 · Cited by 104

Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome

Gallone, G., Baldetti, L., Pagnesi, M., Latib, A., Colombo, A., Libby, P., & Giannini, F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.052 · Cited by 104

Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction

Joshi, N. V., Toor, I. S., Shah, A. S. V., Carruthers, K. F., Vesey, A. T., Alam, S. R., Sills, A., Hoo, T. Y., Melville, A. J., Langlands, S. P., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001956 · Cited by 101

Cytokine SNPs: Comparison of Allele Frequencies by Race & Implications for Future Studies

Dyke, A. L. V., Cote, M., Wenzlaff, A., Land, S., & Schwartz, A. (2009) · Cytokine · doi:10.1016/j.cyto.2009.02.003 · Cited by 97

Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits

Bulgarelli, A., Dias, A. A. M., Caramelli, B., & Maranhão, R. C. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318241c385 · Cited by 95

Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging

van der Valk, F. M., Verweij, S. L., Zwinderman, A. H., Strang, A. C., Kaiser, Y., Marquering, H. A., Nederveen, A. J., Stroes, E. S. G., Verberne, H. J., & Rudd, J. H. F. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.04.007 · Cited by 93

What Can Be Seen by 18F-FDG PET in Atherosclerosis Imaging? The Effect of Foam Cell Formation on 18F-FDG Uptake to Macrophages In Vitro

Ogawa, M., Nakamura, S., Saito, Y., Kosugi, M., & Magata, Y. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092866 · Cited by 91

Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy

Pearson, T. A., Ballantyne, C. M., Veltri, E. P., Shah, A. K., Bird, S. R., Lin, J., Rosenberg, E., & Tershakovec, A. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.090 · Cited by 91

Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers

Aldaham, S. A., Foote, J. A., Chow, H. ‐. S., & Hakim, I. A. (2015) · International Journal of Inflammation · doi:10.1155/2015/439396 · Cited by 86

Negative Risk Markers for Cardiovascular Events in the Elderly

Mortensen, M. B., Fuster, V., Muntendam, P., Mehran, R., Baber, U., Sartori, S., & Falk, E. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.049 · Cited by 84

PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers

Hoogeveen, R. M., Opstal, T. S. J., Kaiser, Y., Stiekema, L. C. A., Kroon, J., Knol, R. J. J., Bax, W. A., Verberne, H. J., Cornel, J. H., & Stroes, E. S. G. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.06.022 · Cited by 83

Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk

King, C. C., Piper, M. E., Gepner, A. D., Fiore, M. C., Baker, T. B., & Stein, J. H. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308728 · Cited by 77

Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes

Falconer, C., Cooper, A. R., Walhin, J., Thompson, D., Page, A. S., Peters, T. J., Montgomery, A. A., Sharp, D., Dayan, C. M., & Andrews, R. C. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.03.009 · Cited by 76

Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia

Leucker, T. M., Gerstenblith, G., Schär, M., Brown, T. T., Jones, S. R., Afework, Y., Weiss, R. G., & Hays, A. G. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016263 · Cited by 75

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies

Pirro, M., Simental‐Mendía, L. E., Bianconi, V., Watts, G. F., Banach, M., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010118 · Cited by 73

Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets

Hulin, A., Hego, A., Lancellotti, P., & Oury, C. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00021 · Cited by 71

Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction

Yin, J., Peng, Y., Wu, J., Wang, Y., & Yao, L. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313143 · Cited by 69

Polymorphisms in the TNF‐α and TNF‐receptor genes in patients with coronary artery disease

Allen, R., Lee, E. M., Roberts, D. H., Park, B. K., & Pirmohamed, M. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00907.x · Cited by 68

Effects of Biochemically Confirmed Smoking Cessation on White Blood Cell Count

Abel, G. A., Hays, J. T., Decker, P. A., Croghan, G. A., Kuter, D. J., & Rigotti, N. A. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1022 · Cited by 66

Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: Results from a multi-ethnic cohort

Veeranna, V., ZALAWADIYA, S. K., Niraj, A., Kumar, A., Ference, B. A., & Afonso, L. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.034 · Cited by 65

Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications

Maiolino, G. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i10.609 · Cited by 65

NF-κB in biology and targeted therapy: new insights and translational implications

Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,405

Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns

Khan, J., Deb, P. K., Priya, S., Damian-Medina, K., Devi, R., Walode, S. G., & Rudrapal, M. (2021) · Molecules · doi:10.3390/molecules26134021 · Cited by 350

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness

Makover, M. E., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100371 · Cited by 139

IL-6 and Cardiovascular Risk: A Narrative Review

Mehta, N. N., deGoma, E. M., & Shapiro, M. D. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01259-7 · Cited by 140

The Brain–Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease

Hu, J., Abdullah, A., Nanna, M. G., & Soufer, R. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01990-8 · Cited by 115

IA 008 Coronary Angiography by Multidetector Computed Tomography Predicts Clinically Driven Revascularization in Suspected Acute Coronary Syndrome Better than in Chronic Stable Coronary Artery Disease

Silva, L., Neto, P., Niinuma, H., Dewey, M., Shapiro, E., Brinker, J., Miller, J. G., Lima, J., & Rochitte, C. E. (2009) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(09)71746-5

THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF ATHEROSCLEROSIS

Kazakova, M., Vysotskaya, K., & Mitkovskaya, N. (2022) · Emergency Cardiology and Cardiovascular Risks · doi:10.51922/2616-633x.2022.6.2.1707 · Cited by 3

Vascular biology of atherosclerosis: overview and state of the art

Libby, P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03143-0 · Cited by 362

Inflammation in coronary artery diseases.

Li, J. (2011) · PubMed · Cited by 30

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

Raggi, P., Genest, J. J., Giles, J. T., Rayner, K. J., Dwivedi, G., Beanlands, R. S., & Gupta, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.014 · Cited by 447